Severe acute respiratory syndrome-associated coronavirus IVDs

Intended purpose

The SARS-CoV-2 IgG/IgM assays are chemiluminescent microparticle immunoassays (CMIA) used for the qualitative, semi-quantitative and quantitative detection of IgG antibodies and qualitative detection of IgM antibodies to SARS-CoV-2 in human clinical specimens.